Pharma shares in focus; Dr Reddy's, Divi's, Granules hit 52-week highs

Lupin, Sun Pharmaceutical, Cadila Healthcare, Aarti Drugs and Aurobindo Pharma were up in the range of 2 per cent to 3 per cent.

Pharma stocks were in focus on Friday with the Nifty Pharma index gaining nearly 2 per cent on report that brokerage firm Citi has upgraded Dr Reddy's to 'buy' from 'sell' and Lupin to 'neutral' from 'sell'. The foreign brokerage also said that valuations of pharma companies look reasonable.

At 10:05 am, Nifty Pharma index was the top gainer among sectoral indices and was trading 1.6 per cent up as compared to 0.44 per cent rise in the benchmark Nifty50 index.

Dr Reddy’s Laboratories, Divi’s Laboratories, Granules India, Alkem Laboratories and Ipca Laboratories hit their respective 52-week highs